Bioline Rx reported $20.83M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Arca Biopharma USD 1.11B 627.83M Jun/2026
Bio Path USD -8.49M 482K Mar/2026
Bioline Rx USD 20.83M 2.64M Mar/2026
Capricor Therapeutics USD 246.22M 32.48M Jun/2026